Current Perspectives in Cardiovascular Medicine

Authors

  • J. Anthony Gomes Professor of Medicine, Director, Clinical Elcctrophysiology Consultative Service and Senior Consultant, The Mount Sinai Medical Center & Icahn School of Medicine, The Zena and Michael A. Wiener, Cardiovascular Institute and The Leona M. and Harry B. Helmsley Charitable Trust Center for Cardiac Electrophysiology, Box 1030, 1 Gustave L. Levy Place, New York, New York 10029, USA

DOI:

https://doi.org/10.12970/2311-052X.2015.03.02.4

Keywords:

 Obesity, polypill, cardiovascular, atherogenesis, genetics

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the United States accounting for approximately 31% of all deaths. There have been significant accomplishments in the diagnosis and treatment of CVD; however, these advances have mostly occurred in the application of cutting edge technology, pharmacotherapy, and surgical techniques to treat the manifestations and symptoms of the disease. Developments in outcomes research and those in atherosclerosis and genetics, as well as in the control of risk factors for CVD are discussed.

References

Mozaffarian D, Benjamin EJ, Go AS, et al. Heart Disease and Stroke Statistics─2015 Update: A Report from the American Heart Association. Circulation 2015; 131: 29-322. http://dx.doi.org/10.1161/CIR.0000000000000152

Go AS, Mozaffarian D, Roger VL, et al. Heart Disease and Stroke Statistics─ 2014 Update: A Report from the American Heart Association. Circulation 2014; 128: 01-267.

Roger VL, Go AS, Lloyd-Jones DM, et al. AHA Statistical Update: Heart Disease and Stroke Statistics-2011 Update: A report from the American Heart Association. Circulation 2012; 127: e6-e245.

Packer DL. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation. https://clinicaltrials.gov/ct2/ show/NCT00911508

Farkouh ME, Domanski M, Sleeper ScD, et al for the FREEDOM Trail Investigators: Strategies for Multivessel Revascularization in patients with Diabetes. N Engl J Med 2012; 367: 2375-84. http://dx.doi.org/10.1056/NEJMoa1211585

Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter Aortic – Valve Replacement with a Self-Expanding Prosthesis. N Engl J Med 2014; 370(19): 1790-98. http://dx.doi.org/10.1056/NEJMoa1400590

Blankenhorn DH, Hodis HN. George Lyman Duff Memorial Lecture. Arterial imaging and atherosclerosis reversal. Arterioscler Thromb, 1994; 14: 177-92. http://dx.doi.org/10.1161/01.ATV.14.2.177

Schell WD, Myers JN. Regression of atherosclerosis: a review. Prog Cardiovasc Dis 1997; 39: 483-96. http://dx.doi.org/10.1016/S0033-0620(97)80041-2

Stein Y, Stein O. Does therapeutic intervention achieve slowing of progression or bona fide regression of atherosclerotic lesions? Arterioscler Thromb Vasc Biol 2001; 21: 183-8. http://dx.doi.org/10.1161/01.ATV.21.2.183

Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9. http://dx.doi.org/10.1038/362801a0

Wissler RW, Vesselinovitch D. Studies of regression of advanced atherosclerosis in experimental animals and man. Ann N Y Acad Sci 1976; 275: 363-78. http://dx.doi.org/10.1111/j.1749-6632.1976.tb43368.x

Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 1990; 85: 1234-41. http://dx.doi.org/10.1172/JCI114558

Feig JE, Shang Y, Rotllan N, et al. Statins Promote the Regression of Atherosclerosis via Activation of the CCR7-Dependent Emigration Pathway in Macrophages. PLoS One 2011; 6(12): e28534. http://dx.doi.org/10.1371/journal.pone.0028534

Nissen SE, Nicholls SJ, SipahiI, et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295: 1556-65. http://dx.doi.org/10.1001/jama.295.13.jpc60002

Miyamoto Y. Okura H, Kume T, et al. Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS. JACC Cardiovasc Imaging 2011; 6: 638-46. http://dx.doi.org/10.1016/j.jcmg.2011.03.014

Dixon SR, Grines CL, Munir A, et al. Analysis of target lesion length before coronary artery stenting using angiography and near-infrared spectroscopy versus angiography alone. Am J Cadiol 2012; 109: 60-6. http://dx.doi.org/10.1016/j.amjcard.2011.07.068

Feig JE, Vengrenyuk Y, Reiser V, et al. Regression of atherosclerosis is characterized by broad changes in the plaque macrophage transcriptome. PLoS One 2012; 7: e39790. http://dx.doi.org/10.1371/journal.pone.0039790

Kass RS. The channelopathies: novel insights into molecular and genetic mechanisms of human disease. J Clin Invest 2005; 115 (8): 1980-6. http://dx.doi.org/10.1172/JCI26011

Martin CA, Matthews GDK, Huang CJ-H. Sudden cardiac death and inherited channelopathy: the basic electrophysiology of the myocyte and myocardium in ion channel disease. Heart 2012; 98: 536-43. http://dx.doi.org/10.1136/heartjnl-2011-300953

Napolitano C, Bloise R, Monteforte N, Priori SG. Sudden cardiac Death and Ion Channelopathies. Long QT, Brugada, Short QT, catecholaminergic Polymorphic Ventricular Tachycardia and Idipathic Ventricular Fibrillation. Circulation 2012; 125: 2072-34. http://dx.doi.org/10.1161/CIRCULATIONAHA.111.055947

Gudbjartsson DF, Helgason H, Gudjonsson S, et al. Large-scale whole-genome sequencing of the Icelandic population. Nature Genetics 2015; 47: 435-44. http://dx.doi.org/10.1038/ng.3247

Hare JM, Traverse JH, Henry TD, et al. A Randomized, Double-Blind Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (prochymal) After Myocardial Infarction. J Am Coll Cardiol 2009; 54: 277-86. http://dx.doi.org/10.1016/j.jacc.2009.06.055

Hare JM, Fishman JE, Gerstenblith G, et al. Comaparison of Allogenicvs Autologous Bone marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy. The Poseidon Randomized Trial. JAMA 2012; 308(22): E1-E7. http://dx.doi.org/10.1001/jama.2012.25321

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblasts cultures by defined factors. Cell 2006; 126(4): 663-76. http://dx.doi.org/10.1016/j.cell.2006.07.024

Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 228(7151): 313-7. http://dx.doi.org/10.1038/nature05934

San Roman JA, Sanchez PL, Villa A, et al. Comparison of different Bone Marrow derived Stem Cells approaches in Reperfused STEMI. JACC 2015; 65(22): 2372-2382. http://dx.doi.org/10.1016/j.jacc.2015.03.563

Yaniz–Galende E, Chen J, Chemaly E, et al. Stem cell factor gene transfer promotes cardiac repair after myocardial infarctionvia in situ recruitment and expansion of c-kit cells. Circ Res 2012; 111: 1434-1445. http://dx.doi.org/10.1161/CIRCRESAHA.111.263830

Takeuchi F, McGinnis R, Bourgeous S, et al. A genome –Wide Association Study Confirms VKORC1, CYP2C9 and CYP4F2 as Principal Genetic Determinants of Warfarin Dose. PLoS Genet 2009; 5(3): e1000433. http://dx.doi.org/10.1371/journal.pgen.1000433

Lenfant C. Cardiovascular Research: A look into Tomorrow Circulation Research 2001; 88: 253-55.

James PA, Oparil S, Carter BL, et al. Evidence-Based Guideline for the Management of High Blood Pressure in Adults. JAMA 2014; 312(3): 507-520. http://dx.doi.org/10.1001/jama.2013.284427

Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401. http://dx.doi.org/10.1056/NEJMoa1402670

Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. Circ 2014; 129: 51-S45. http://dx.doi.org/10.1161/01.cir.0000437738.63853.7a

Sang G, Fuster V. Prevention. Polypill for cardiovascular prevention: a step forward? Nat Rev Cardiol 2013; 10: 683-4. http://dx.doi.org/10.1038/nrcardio.2013.157

Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326(7404): 1419-23. http://dx.doi.org/10.1136/bmj.326.7404.1419

Thom S, Poulter N, Field J, et al. Effects of a Fixed Dose Combination Strategy on adherence and Risk factors in patients with or at high risk of CVD. The UMPIRE Randomized Clinical Trial. JAMA 2013; 310 (9): 918-929. http://dx.doi.org/10.1001/jama.2013.277064

Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Human gut microbes associated with obesity. Nature 2006; 444: 21-28. http://dx.doi.org/10.1038/4441022a

Downloads

Published

2015-12-03

Issue

Vol. 3 No. 2 (2015)

Section

Articles